Tetrabenazine
18 NDCs across 9 manufacturers|18 Generic,0 Brand
Tetrabenazine is used to treat huntington disease and hyperkinesis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 15, 2008, and the first generic was approved Aug 17, 2015. FDA's Orange Book lists 17 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $47 million on Tetrabenazine across 28,000 claims for 4,140 beneficiaries.
Tetrabenazine is available as 18 NDCs from 9 manufacturers (18 generic, 0 brand), with NADAC prices from $0.70 to $1.35 per EA — a 92% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
18
18G / 0B
Manufacturers
9
competing in market
Price Spread
$0.70 – $1.35
per EA
7d Activity
avg -4.0% WoW · of 18 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Oceanside Pharmaceuticals manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Vesicular Monoamine Transporter 2 Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
9 manufacturers producing TETRABENAZINE(3 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TETRABENAZINE 25 MG TABLET | $1.3500 per EA | — |
TETRABENAZINE 25 MG TABLET | $1.3363 per EA | -0.26% |
TETRABENAZINE 25 MG TABLET | $1.3363 per EA | -0.26% |
TETRABENAZINE 25 MG TABLET | $1.3363 per EA | -0.26% |
TETRABENAZINE 25 MG TABLET | $1.3363 per EA | -0.26% |
TETRABENAZINE 25 MG TABLET | $1.3363 per EA | -0.26% |
TETRABENAZINE 25 MG TABLET | $1.3363 per EA | -0.26% |
TETRABENAZINE 25 MG TABLET | $1.2871 per EA | — |
TETRABENAZINE 25 MG TABLET | $1.2044 per EA | — |
TETRABENAZINE 12.5 MG TABLET | $0.8043 per EA | — |
TETRABENAZINE 12.5 MG TABLET | $0.7679 per EA | — |
TETRABENAZINE 12.5 MG TABLET | $0.7645 per EA | — |
TETRABENAZINE 12.5 MG TABLET | $0.7019 per EA | -7.69% |
TETRABENAZINE 12.5 MG TABLET | $0.7019 per EA | -7.69% |
TETRABENAZINE 12.5 MG TABLET | $0.7019 per EA | -7.69% |
TETRABENAZINE 12.5 MG TABLET | $0.7019 per EA | -7.69% |
TETRABENAZINE 12.5 MG TABLET | $0.7019 per EA | -7.69% |
TETRABENAZINE 12.5 MG TABLET | $0.7019 per EA | -7.69% |
Frequently Asked Questions
What is Tetrabenazine used to treat?
Tetrabenazine is used to treat huntington disease and hyperkinesis, per the National Library of Medicine's MED-RT classification.
When did Tetrabenazine become available as a generic?
FDA approved the first generic Tetrabenazine (ANDA) on Aug 17, 2015. The Orange Book currently lists 17 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Tetrabenazine?
In 2024, Medicare Part D spent $47 million on Tetrabenazine across 28,000 claims for 4,140 beneficiaries.
How many Tetrabenazine products are on the market?
The Tetrabenazine drug market contains 18 NDCs from 9 manufacturers — 18 generic and 0 brand products.
What is the price range for Tetrabenazine?
NADAC reference prices for Tetrabenazine range from $0.7019 to $1.3500 per EA — a 92% difference between cheapest and most expensive.
Which manufacturers make Tetrabenazine?
9 manufacturers list Tetrabenazine in NADAC. Ranked by number of NDCs, the largest are Oceanside Pharmaceuticals (2), Bionpharma Inc. (2), Camber Pharmaceuticals Inc. (2), Apotex Corp. (2), Precision Dose Inc. (2).
How has the price of Tetrabenazine changed recently?
Over the past 7 days, 0 Tetrabenazine NDCs rose and 12 fell, with a market-wide average change of -4.0%.